The European Medicines Agency [EMA] today issued a press release regarding GlaxoSmithKline's Pandemrix vaccine. It's more bad news for Glaxo as the EMA have decided to restrict its use in children and teenagers because of a link to narcolepsy.
Narcolepsy is a chronic sleep disorder, or dyssomnia, characterized by an excessive urge to sleep at inappropriate times and in Finnish and Swedish studies there was a 6- to 13-fold increase risk of narcolepsy in young people who had received the Pandemrix vaccine.
The EMA have recommended a labeling change that limits the vaccine's use in children and teens to when protection is needed and seasonal trivalent vaccine isn't available. In other words, it won't be used as a first line treatment.
GSK have issue a press release on their webpage, the end paragraph is classic:
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.
Pardon the pun but...Zzzzzzzzzzzzz
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
US & CANADA HERE OR UK FROM CHIPMUNKA PUBLISHING
AUSTRALIAN ORDERS HERE